| POLAR CAPITAL BIOTECHNOLOGY R GBP DIS | RVI BIOTECNOLOGÍA | 69,276862 | 26/08/2026 | 27,21% | 105,23% | **** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY C CAP USD | RVI BIOTECNOLOGÍA | 1.272,131288 | 26/08/2026 | 27,15% | 81,01% | *** |
| POLAR CAPITAL BIOTECHNOLOGY R EUR DIS | RVI BIOTECNOLOGÍA | 69,200000 | 26/08/2026 | 27,14% | 105,40% | **** |
| FRANKLIN BIOTECHNOLOGY DISCOVERY I (ACC) USD | RVI BIOTECNOLOGÍA | 103,385037 | 26/08/2026 | 27,07% | 109,21% | ***** |
| FRANKLIN BIOTECHNOLOGY DISCOVERY W (ACC) USD | RVI BIOTECNOLOGÍA | 32,264976 | 26/08/2026 | 27,01% | 108,81% | ***** |
| JPM THEMATICS-GENETIC THERAPIES C2 (ACC) GBP (HEDGED) | RVI BIOTECNOLOGÍA | 167,638092 | 26/08/2026 | 27,00% | 43,43% | ** |
| JPM THEMATICS-GENETIC THERAPIES C2 (DIST) GBP (HEDGED) | RVI BIOTECNOLOGÍA | 165,745856 | 26/08/2026 | 27,00% | 42,05% | ** |
| POLAR CAPITAL BIOTECHNOLOGY R USD DIS | RVI BIOTECNOLOGÍA | 69,063330 | 26/08/2026 | 26,95% | 105,74% | **** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY N CAP USD | RVI BIOTECNOLOGÍA | 898,868798 | 26/08/2026 | 26,85% | 79,05% | *** |
| POLAR CAPITAL BIOTECHNOLOGY R EUR CAP | RVI BIOTECNOLOGÍA | 10,440000 | 26/08/2026 | 26,85% | · | ND |
| POLAR CAPITAL BIOTECHNOLOGY R USD CAP | RVI BIOTECNOLOGÍA | 10,420773 | 26/08/2026 | 26,75% | · | ND |
| FRANKLIN BIOTECHNOLOGY DISCOVERY A (ACC) SGD | RVI BIOTECNOLOGÍA | 46,534386 | 26/08/2026 | 26,58% | 104,05% | ***** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY C DIS USD | RVI BIOTECNOLOGÍA | 1.148,453167 | 26/08/2026 | 26,48% | 77,86% | *** |
| FRANKLIN BIOTECHNOLOGY DISCOVERY A (ACC) HKD | RVI BIOTECNOLOGÍA | 5,316904 | 26/08/2026 | 26,41% | 103,85% | ***** |
| FRANKLIN BIOTECHNOLOGY DISCOVERY A (ACC) USD | RVI BIOTECNOLOGÍA | 63,792956 | 26/08/2026 | 26,36% | 103,93% | ***** |
| FRANKLIN BIOTECHNOLOGY DISCOVERY N (ACC) USD | RVI BIOTECNOLOGÍA | 51,923901 | 26/08/2026 | 25,74% | 99,43% | **** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY I-H CAP EUR | RVI BIOTECNOLOGÍA | 3.480,860000 | 26/08/2026 | 25,31% | 84,70% | *** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY R-H CAP EUR | RVI BIOTECNOLOGÍA | 351,320000 | 26/08/2026 | 25,18% | 87,47% | *** |
| JPM THEMATICS-GENETIC THERAPIES I2 (ACC) USD | RVI BIOTECNOLOGÍA | 89,964864 | 26/08/2026 | 25,11% | 33,36% | ** |
| JPM THEMATICS-GENETIC THERAPIES C2 (ACC) USD | RVI BIOTECNOLOGÍA | 122,846859 | 26/08/2026 | 25,09% | 33,23% | ** |
